• About us
• Contact

Advertisement

Product › Details

fostamatinib (R788)

	Next higher product group	kinase inhibitor_o
	Status	2019-01-23 sales existent
	Organisation	Rigel Pharmaceuticals Inc. (Nasdaq: RIGL)

Record changed: 2023-07-10

Advertisement

More documents for kinase inhibitor_o

• [1] Ryvu Therapeutics S.A.. (12/22/22). "Press Release: Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds over PLN 250 Million". Krakow....
• [2] Ryvu Therapeutics S.A.. (12/8/22). "Press Release: Ryvu Therapeutics Initiates Public Offering of Shares [not for US, AU, CA, et al.]". Krakow....
• [3] Ryvu Therapeutics S.A.. (7/26/22). "Press Release: Ryvu Therapeutics Announces Promotion of Hendrik Nogai and Vatnak Vat-Ho to the Management Board". Kraków....
• [4] Ryvu Therapeutics S.A.. (3/15/22). "Press Release: Ryvu Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update". Krakow....
• [5] Ryvu Therapeutics S.A.. (4/26/21). "Press Release: Ryvu Therapeutics Appoints Vatnak Vat-Ho as Chief Business Officer". Krakow....
• [6] Ryvu Therapeutics S.A.. (3/16/21). "Press Release: Ryvu Therapeutics Reports Financial Results for 2020". Kraków....
• [7] Selvita S.A.. (5/22/19). "Press Release: Selvita Reports First Quarter 2019 Financial Results and Provides Corporate Update". Krakow....
• [8] Selvita S.A.. (3/28/19). "Press Release: Selvita to Separate Oncology Therapeutics and Contract Research Business Units into Two Global Companies". Krakow....
• [9] Selvita S.A.. (3/28/19). "Press Release: Selvita Posts 67 Percent Increase in Operating Profit for Services Division, Innovative Research Division Reaches Inflection Point as SEL120 Enters Clinical Development". Krakow....
• [10] Grifols S.A.. (1/23/19). "Press Release: Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals to Commercialize Fostamatinib in Europe". Barcelona....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.